Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-19

Clinical Trial Update: Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of dapagliflozin for hospital management in patients with type 2 diabetes, including those with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Medanta, The Medicity, India | Conditions: Type2diabetes, Coronary Artery Disease | Phase 4 | Status: COMPLETED